Mirae Asset Global Etfs Holdings Ltd. Guardant Health, Inc. Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $43.9 Billion
- Q4 2024
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Guardant Health, Inc. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 67,180 shares of GH stock, worth $2.95 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
67,180
Previous 64,618
3.96%
Holding current value
$2.95 Million
Previous $1.48 Million
38.56%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding GH
# of Institutions
348Shares Held
120MCall Options Held
793KPut Options Held
1.85M-
Vanguard Group Inc Valley Forge, PA12.1MShares$529 Million0.01% of portfolio
-
Black Rock Inc. New York, NY11.2MShares$493 Million0.01% of portfolio
-
Deep Track Capital, LP Greenwich, CT6.42MShares$281 Million8.64% of portfolio
-
Baillie Gifford & CO5.45MShares$239 Million0.13% of portfolio
-
Cadian Capital Management, LP New York, NY5.22MShares$229 Million9.25% of portfolio
About Guardant Health, Inc.
- Ticker GH
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 102,220,000
- Market Cap $4.48B
- Description
- Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...